Breaking News Instant updates and real-time market news.

XLRN

Acceleron

$47.11

-0.68 (-1.42%)

07:09
07/13/18
07/13
07:09
07/13/18
07:09

Acceleron downgraded to Equal Weight from Overweight at Morgan Stanley

XLRN Acceleron
$47.11

-0.68 (-1.42%)

06/29/18
JPMS
06/29/18
NO CHANGE
Target $54
JPMS
Overweight
Acceleron shares have 30%-35% upside on 'clean win,' says JPMorgan
In a research note partially titled "Gooooal! A Clean Win for MEDALIST Phase 3," JPMorgan analyst Eric Joseph raised his price target for Acceleron Pharma to $54 from $52. While details on specific endpoints were light, the top-line announcement notes highly significant outcomes on both primary and key secondary endpoint, Joseph writes. The analyst views the outcome as a "clean win" that and "materially de-risks" the path forward to approval for luspatercept. He sees 30%-35% upside to current levels for Acceleron shares on higher probability of success assumptions across Street models on myelodysplastic syndromes alone. Joseph keeps an Overweight rating on Acceleron. The stock in premarket trading is up 26.5% to $43.00.
07/10/18
PIPR
07/10/18
DOWNGRADE
Target $52
PIPR
Neutral
Acceleron downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff downgraded Acceleron Pharma (XLRN) to Neutral and lowered his price target for the shares to $52 from $55. Acceleron and partner Celgene (CELG) last night announced positive Phase III Believe results for luspatercept in transfusion dependent beta thalassemia, Tenthoff tells investors in a research note. The stock in premarket trading is up $6.10, or 13%, to $53.50. This is a nice second win for luspatercept, but Acceleron shares are not a buy at current valuation levels, the analyst contends. He believes luspatercept does not command the same market opportunity in beta thalassemia due to the expected approval of curative gene therapy by 2020. As such, Tenthoff lowered his penetration rates for luspatercept in beta thal to account for gene therapy competition. He says, however, that partner Celgene could acquire Acceleron, which presents a risk to his downgrade.
07/10/18
UBSW
07/10/18
NO CHANGE
Target $62
UBSW
Buy
Acceleron price target raised to $62 from $57 at UBS
UBS analyst Carter Gould raised his price target for Acceleron Pharma to $62 citing the positive results from the Phase 3 Believe study of luspatercept in beta-thalassemia. While not a surprise after the positive Medalist data two weeks ago, a "clear clinical win" was important given a lack of quantitative details in either press release, Gould tells investors in a research note. He keeps a Buy rating on Acceleron.
07/10/18
HCWC
07/10/18
NO CHANGE
Target $74
HCWC
Buy
Acceleron price target raised to $74 from $69 at H.C. Wainwright
H.C. Wainwright analyst Edward White raised his price target for Acceleron Pharma to $74 citing the positive results from the Phase 3 Believe study of luspatercept in transfusion-dependent beta-thalassemia patients. The analyst expects sales in 2020 of $31M, growing to $260M in 2026. He keeps a Buy rating on Acceleron.

TODAY'S FREE FLY STORIES

PX

Praxair

$158.82

2.62 (1.68%)

, LNEGY

Linde

$0.00

(0.00%)

11:27
10/15/18
10/15
11:27
10/15/18
11:27
Hot Stocks
Linde, Praxair announce squeeze-out of remaining Linde shareholders »

Linde (LNEGY) and Praxair…

PX

Praxair

$158.82

2.62 (1.68%)

LNEGY

Linde

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$73.76

-0.73 (-0.98%)

11:25
10/15/18
10/15
11:25
10/15/18
11:25
Conference/Events
Economic Club of Washington, D.C. to hold luncheon meeting »

Luncheon Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

S

Sprint

$6.35

-0.04 (-0.63%)

11:20
10/15/18
10/15
11:20
10/15/18
11:20
Options
Size ratio spread in Sprint »

Size ratio spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

11:20
10/15/18
10/15
11:20
10/15/18
11:20
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
10/15/18
10/15
11:17
10/15/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAN

Huntington Bancshares

$14.29

-0.08 (-0.56%)

11:17
10/15/18
10/15
11:17
10/15/18
11:17
Technical Analysis
Technical Take: Huntington Bancshares breaks support »

The shares are down 0.7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

PAR

PAR Technology

$20.31

-0.69 (-3.29%)

11:16
10/15/18
10/15
11:16
10/15/18
11:16
Hot Stocks
Voss Capital supports ADW's call for PAR Technology board to pursue alternatives »

Voss Capital, LLC, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
10/15/18
10/15
11:16
10/15/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$59.01

-0.67 (-1.12%)

11:15
10/15/18
10/15
11:15
10/15/18
11:15
Options
Weibo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
10/15/18
10/15
11:15
10/15/18
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

11:15
10/15/18
10/15
11:15
10/15/18
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:13
10/15/18
10/15
11:13
10/15/18
11:13
Hot Stocks
Breaking Hot Stocks news story  »

Bio Rad Laboratories…

11:10
10/15/18
10/15
11:10
10/15/18
11:10
General news
Treasury announced a $25 B 8-week bill for the inaugural sale Tuesday »

Treasury announced a $25…

TXT

Textron

$65.88

0.81 (1.24%)

11:06
10/15/18
10/15
11:06
10/15/18
11:06
Hot Stocks
TRU Simulation + Training, FlightSafety International enter LOI to form JV »

TRU Simulation +…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

11:05
10/15/18
10/15
11:05
10/15/18
11:05
Hot Stocks
Breaking Hot Stocks news story  »

Bio Rad Laboratories…

11:05
10/15/18
10/15
11:05
10/15/18
11:05
General news
Today's U.S. reports »

Today's U.S. reports…

MANU

Manchester United

$21.87

0.59 (2.77%)

11:03
10/15/18
10/15
11:03
10/15/18
11:03
Periodicals
Manchester United target for possible takeover by Saudi prince, The Sun says »

Saudi Crown Prince…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTAP

NetApp

$75.53

-1.43 (-1.86%)

, EQIX

Equinix

$399.68

3.96 (1.00%)

11:03
10/15/18
10/15
11:03
10/15/18
11:03
Hot Stocks
NetApp appoints Debra McCowan as chief human resources officer »

NetApp (NTAP) announced…

NTAP

NetApp

$75.53

-1.43 (-1.86%)

EQIX

Equinix

$399.68

3.96 (1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 01

    Nov

  • 07

    Nov

  • 07

    Nov

  • 10

    Dec

SMH

Market Vectors Semiconductor

$96.42

-0.92 (-0.95%)

11:03
10/15/18
10/15
11:03
10/15/18
11:03
Technical Analysis
Technical Take: Market Vectors Semiconductor breaks support, nears 52-week lows »

The Market Vectors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMB

iShares JP Morgan USD Emerging Markets Bond ETF

$105.88

0.04 (0.04%)

11:00
10/15/18
10/15
11:00
10/15/18
11:00
Options
Position adjustment in Emerging Markets bond ETF »

Position adjustment in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$5.25

0.11 (2.14%)

10:58
10/15/18
10/15
10:58
10/15/18
10:58
Hot Stocks
Viceroy: MiMedx's appointment of Alvarez, Marsal 'conflict of interest' »

In an open letter to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ATVI

Activision Blizzard

$74.92

-3.07 (-3.94%)

, MCD

McDonald's

$164.56

0.74 (0.45%)

10:57
10/15/18
10/15
10:57
10/15/18
10:57
Recommendations
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's…

ATVI

Activision Blizzard

$74.92

-3.07 (-3.94%)

MCD

McDonald's

$164.56

0.74 (0.45%)

TPR

Tapestry

$42.89

-0.92 (-2.10%)

LULU

Lululemon

$143.24

-0.46 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 23

    Oct

  • 19

    Nov

10:55
10/15/18
10/15
10:55
10/15/18
10:55
Conference/Events
Wedbush restaurants analyst to hold a luncheon »

Restaurants Analyst…

WPC

W.P. Carey

$63.80

0.61 (0.97%)

, GPN

Global Payments

$115.68

-1.72 (-1.47%)

10:54
10/15/18
10/15
10:54
10/15/18
10:54
Conference/Events
Wedbush IT services & payments analyst to hold dinner meeting »

In conjunction with the…

WPC

W.P. Carey

$63.80

0.61 (0.97%)

GPN

Global Payments

$115.68

-1.72 (-1.47%)

FDC

First Data

$23.21

0.02 (0.09%)

TSS

TSYS

$92.71

-1.235 (-1.31%)

SQ

Square

$73.51

-0.455 (-0.62%)

PYPL

PayPal

$77.74

-1.28 (-1.62%)

MA

MasterCard

$200.90

-3.06 (-1.50%)

V

Visa

$138.45

-1.57 (-1.12%)

ADS

Alliance Data

$211.66

-2.09 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 21

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 13

    Nov

  • 26

    Nov

  • 03

    Mar

UNFI

United Natural Foods

$26.66

-0.48 (-1.77%)

, SVU

Supervalu

$32.47

-0.005 (-0.02%)

10:54
10/15/18
10/15
10:54
10/15/18
10:54
Recommendations
United Natural Foods, Supervalu analyst commentary  »

RBC says United Natural…

UNFI

United Natural Foods

$26.66

-0.48 (-1.77%)

SVU

Supervalu

$32.47

-0.005 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.